Vitis para Inflamación sistémica o localizada
Vitis shuttleworthii — 8 estudios científicos revisados
Moderate¿Sirve Vitis para inflamación sistémica o localizada?
Los oligostilbenos y otros fitoquímicos presentes poseen propiedades antiinflamatorias que pueden modular las vías de señalización de mediadores proinflamatorios en el organismo.
Compuestos activos involucrados:
Evidencia Científica
Los siguientes estudios han investigado la relación entre Vitis y inflamación sistémica o localizada:
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM.
Candida species are the predominant cause of fungal infections in patients treated in hospital, contributing substantially to morbidity and mortality. Candidaemia and other forms of invasive candidiasis primarily affect patients who are immunocompromised or critically ill. In contrast, mucocutaneous forms of candidiasis, such as oral thrush and vulvovaginal candidiasis, can occur in otherwise healthy individuals. Although mucocutaneous candidiasis is generally not life-threatening, it can cause considerable discomfort, recurrent infections, and complications, particularly in patients with unde
PubMed: 39956121Vitis amurensis Rupr: A review of chemistry and pharmacology.
PURPOSE: Vitis amurensis Rupr. from the family Vitaceae, is a grape species native to the Asian continent. It is a highly attractive plant, used widely worldwide. It has been used for several hundred years as a traditional Chinese herb. The review focuses on the botanical description, traditional uses, phytochemistry, and the biological activities of Vitis amurensis Rupr.
PubMed: 30217258Anticancer, Cardio-Protective and Anti-Inflammatory Potential of Natural-Sources-Derived Phenolic Acids.
Phenolic acids (PAs) are one of the utmost prevalent classes of plant-derived bioactive chemicals. They have a specific taste and odor, and are found in numerous medicinal and food plants, such as
PubMed: 36364110Vitis Vinifera Seed Extract Versus Micronized Purified Flavonoid Fraction for Patients with Chronic Venous Disease: A Randomized Noninferiority Trial.
BACKGROUND: Venoactive drugs (VADs) based on Vitis vinifera extract are widely used in Korea. However, studies on the clinical effects and head-to-head comparisons with other groups of VADs are limited. This trial aimed to evaluate whether Vitis vinifera seed extract was noninferior to the micronized purified flavonoid fraction (MPFF) in relieving venous symptoms and improving quality of life in patients with chronic venous disease. METHODS: In this double-blind prospective randomized trial, patients from 13 hospitals, who were diagnosed with venous incompetence by duplex ultrasound and classi
PubMed: 39009117Medicinal plants as a potential source of Phosphodiesterase-5 inhibitors: A review.
ETHNOPHARMACOLOGICAL RELEVANCE: The prevalence and distress caused by erectile dysfunction (ED) to both male and female partners are increasing at a steady rate. ED has now become the most treated sexual disorder for men among young and old age groups due to varying physical and psychological factors. The treatment with synthetic Phosphodiesterase-5 (PDE5) inhibitors are cost-effective but due to adverse effects such as priapism, loss of vision, heart attack and syncope, the daily life patterns of these patients are distressed and hence the need for alternative medicaments or sources are of ut
PubMed: 33137431Seguridad y Precauciones
Debido a la naturaleza bioquímica de los compuestos presentes en el género Vitis, especialmente los polifenoles como los estilbenos y flavonoides, la seguridad debe abordarse con rigor clínico. En el caso de mujeres en periodo de embarazo y lactancia, no existe evidencia científica suficiente que garantice la ausencia de efectos teratogénicos (malformaciones fetales) o alteraciones en el desarrollo del lactante mediante el consumo de extractos de Vitis. Dado que los compuestos bioactivos pueden atravesar la barrera placentaria o ser excretados en la leche materna, se recomienda evitar su uso terapéutico durante estas etapas para prevenir riesgos impredecibles. Para niños menores de 12 años, el uso debe ser estrictamente evitado, ya que los sistemas enzimáticos y metabólicos en desarrollo son más sensibles a la modulación hormonal o a la carga de antioxidantes concentrados, y no se han establecido dosis seguras para esta población pediátrica. En cuanto a las interacciones farmacológicas, el consumo de Vitis puede interferir con la terapia con warfarina y otros anticoagulantes orales; los compuestos fenólicos pueden alterar la cascada de coagulación, incrementando el riesgo de hemorragias. Asimismo, existe un riesgo de interacción con la metformina, ya que los compuestos de la planta podrían potenciar efectos hipoglucemiantes, llevando a episodios de hipoglucemia.
Otras plantas estudiadas para Inflamación sistémica o localizada
Perfil completo: Ver todos los usos y evidencia de Vitis →